Publication | Closed Access

A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury

InflammationAutoimmune DiseaseHepatologyNovel Cell-based AssayMedicineLiver PhysiologyImmunologyHepatitisInflammatory MarkerHepatology InflammationHepatotoxicityAcute Liver FailureLiver DiseaseInflammatory-related Gene ExpressionPharmacologyDrug-induced Liver Injury